Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer - Authors' reply

Lancet Oncol. 2020 Dec;21(12):e546. doi: 10.1016/S1470-2045(20)30689-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carboplatin
  • Etoposide
  • Humans
  • Lung Neoplasms*
  • Neoplasm Recurrence, Local
  • Topotecan*

Substances

  • Etoposide
  • Topotecan
  • Carboplatin